TGFB1 and diabetic kidney disease: One potential mechanism underlying butyrate nephroprotective effect on DKD involves histone butyrylation modification [69] and the inhibition of histone deacetylases (HDACs) [70], leading to amelioration of eNOS, iNOS, and TGFβ1-induced DNA damage, fibrosis and apoptosis.